How much revenue does Affymax make?

Affymax reported $1.37 million in revenue for fiscal year 2013, down 98.5% from $94.37 million in fiscal year 2012. In Q2 2014 revenue was $42,000.

What companies are similar to Affymax?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Rafarma Pharmaceuticals, Inc. (RAFA), Cannabis Strategic Ventures (NUGS), Amazonas Florestal, Ltd (AZFL), SK3 Group, Inc. (SKTO).

Affymax, Inc. (AFFY) Stock

About Affymax, Inc.

Affymax, Inc. does not have significant operations. Previously, it was developing drugs to enhance the treatment of serious and often life-threatening conditions in the United States. The company was founded in 2001 and is based in New York, New York.

At a glance

Affymax reported revenue of $1.37 million for fiscal year 2013, down 98.5% from fiscal year 2012, and net income of -$14.42 million. In Q2 2014 (the quarter ended June 30, 2014) revenue was $42,000, down 92.0% from a year before.

Figures from company filings; latest fiscal year ended December 31, 2013.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.